Management [ocac]
Atherogenesis [patf]
Dyslipidaemia [dsyn]
Metabolic syndrome [dsyn]
Evolving [ftcn]
Rationale [idcn]
Combined therapy [topp]
Drug [phsu]
Atherogenesis [patf]
Dyslipidaemia [dsyn]
Prevalence [qnco]
Various [irda]
condition [dsyn]
Associated [qlco]
Central Obesity [dsyn]
Hypertension [dsyn]
Impaired [ftcn]
Beta cell [cell]
function [phsf]
Metabolic syndrome [dsyn]
Clinical Trial [resa]
Evidence [ftcn]
High Risk [qlco]
Patients [podg]
Atherogenesis [patf]
Dyslipidaemia [dsyn]
Statin [orch, phsu]
therapy [ftcn]
Drugs [phsu]
Targeted [ftcn]
reduction [npop]
Low density lipoprotein [aapp, bacs, lipd]
Precursor [idcn]
Likely [qlco]
Metabolic Profile [npop]
Non [ftcn]
High Density Lipoproteins [aapp, bacs, lipd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Large [qnco]
Scale [medd]
Clinical Trials [resa]
Combined therapy [topp]
Drug [phsu]
Show [inpr]
Coronary heart disease risk [inpr]
reduction [npop]
Improvement [cnce]
coronary heart disease [dsyn]
Needed [qlco]
Possible [qlco]
New [tmco]
Drugs [phsu]
Needed [qlco]
To [qlco]
Target [ftcn]
Fatty Acid Metabolism [moft]
Inflammation [patf]
Understanding [menp]
Metabolic [ftcn]
origins [clas]
Atherogenesis [patf]
Dyslipidaemia [dsyn]
increases [ftcn]
Possible [qlco]
New [tmco]
Target [ftcn]
therapy [ftcn]
Identified [qlco]
New [tmco]
Drug Combinations [phsu]
To [qlco]
Efficacy [qlco]
Currently [tmco]
Available [ftcn]
treatment [ftcn]
condition [dsyn]
